‘Time machine’ offers new pancreatic cancer drug testing approach
Purdue engineers built a “time machine,” or microfluidic pancreatic tumor device, that simulates tumor growth over time. Credit: Purdue University/Jared Pike Many patients with pancreatic cancer have only about a 10% chance of survival within five years of their diagnosis because they tend to become resistant to chemotherapy, past studies have indicated. A “time machine” […]
New map of the immune landscape in pancreatic cancer could guide immunotherapy — ScienceDaily
Stubbornly, frustratingly, pancreatic cancer has remained resistant to immunotherapies that are revolutionizing the treatment of many types of cancer. A new study led by the University of Michigan Rogel Cancer Center combined single-cell RNA sequencing with two other investigative techniques to create what is believed to be the most robust and detailed portrait to date […]
